[ Price : $8.95]
FDA releases labeling changes approved in September for 37 drugs.[ Price : $8.95]
FDA changes labeling for Genentechs Invirase to add information on a potential change in heart electrical activity when it is used...[ Price : $8.95]
MacroGenics and Lilly end trials of Protege after it fails to meet efficacy endpoints in a Phase 3 Type 1 diabetes study.[ Price : $8.95]
Neoprobe says it has sent a RIGScan BLA response letter to FDA as the first of several planned steps in reactivating the applicati...[ Price : $8.95]
FDA says it has detected high levels of peroxide in one lot of Crospovidone manufactured by a Chinese firm.[ Price : $8.95]
FDA approves a Boehringer Ingelheim Pharmaceuticals NDA for Pradaxa capsules (dabigatran etexilate) for preventing stroke and bloo...[ Price : $8.95]
An FDA complete response letter asks for a QT study and other information on Amylins NDA for its Type 2 diabetes drug Bydureon.[ Price : $8.95]
Aastrom Bioscience submits an SPA to FDA for a Phase 3 clinical development program in critical limb ischemia.